摘要
目的:观察丹红注射液对不稳定型心绞痛(Unstable Angina Pectoris,UA)血瘀证患者择期经皮冠状动脉介入治疗(Percutaneous CoronaryIntervention,PCI)围手术期血清代谢组学的影响。方法:采用前瞻性、随机、对照、单盲的临床研究方法,选取2018年7月至2019年1月首都医科大学附属北京中医医院行PCI的中医证属血瘀证的UA患者61例作为研究对象,采用随机数字表法随机分为丹红组(n=31)和对照组(n=30)。丹红组采用西医规范治疗+丹红注射液治疗,对照组采用西医规范治疗+生理盐水,纳入健康志愿者10例。应用非靶向代谢组学方法对丹红组、对照组治疗前、PCI术后5 d及健康志愿者血清代谢产物进行分析。结果:治疗前,丹红组与对照组血清代谢产物谱比较,差异无统计学意义(P>0.05);治疗前,丹红组及对照组与健康组有较大的差异,差异代谢物包括甘油磷脂代谢、鞘脂代谢、嘌呤代谢、氨基酸代谢等代谢通路中相关代谢产物;PCI术后5 d,丹红组与对照组患者的血清代谢物谱均趋向健康组,与治疗前比较差异有统计学意义(P<0.05);术后丹红组患者的血清代谢物谱较对照组更接近健康组水平,差异有统计学意义(P<0.05)。结论:在西医规范治疗基础上使用丹红注射液,可使患者血清代谢产物水平更接近健康人群。
Objective:To observe the effects of Danhong Injection on perioperative serum metabonomics in patients with blood stasis syndrome of unstable angina pectoris(UA)by using percutaneous coronary intervention(PCI)in a certain period.Methods:A prospective,randomized,controlled,single blind clinical trial was conducted.A total of 61 UA patients with TCM blood stasis syndrome undergoing elective PCI were selected as the research objects and were randomly divided into a Danhong group(n=31)and a control group(n=30),and 10 healthy volunteers were included as baseline.Danhong group received Western medicine+DHI treatment,the control group received Western medicine+saline.Non-targeted metabolomics methods were used to analyze the serum metabolites of Danhong group,and control group before treatment,5 days after PCI and serum metabolites of healthy volunteers.Results:Before treatment,there was no significant difference in serum metabolites between the Danhong group and the control group.Before treatment,there was significant difference among the above 2 groups and the healthy group.Differential metabolites mainly included glycerophospholipid,sphingolipid,purine,and amino acid groups,which were generated in their metabolic pathways.After 5 days of PCI,the profiles of serum metabolites were significantly closer to the healthy group.Compared with before treatment,there was a statistical difference;the serum metabolite profile of patients in the Danhong group was closer to the level of the healthy group than the control group,and the difference was statistically significant.Conclusion:The use of Danhong Injection on the basis of Western medicine standard treatment can make the patient′s serum metabolite level closer to healthy people.
作者
牛芊
邢文龙
刘红旭
王雨桐
朱彦
NIU Qian;XING Wenlong;LIU Hongxu;WANG Yutong;ZHU Yan(Beijing University of Traditional Chinese Medicine,Beijing 100029,China;Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital Medical University,Beijing,100010,China;Capital Medical University,Beijing 100069,China;Tianjin University of Traditional Chinese Medicine,Tianjin 301617,China)
出处
《世界中医药》
CAS
2021年第12期1900-1908,共9页
World Chinese Medicine
基金
国家自然科学基金面上项目(81273741)
北京市自然科学基金项目(7142077)
许夏基金项目(XX-201710)
北京中医医院院级课题暨两院合作课题(YJ201720)。
关键词
不稳定型心绞痛
血瘀证
丹红注射液
代谢组学
代谢通路
经皮冠状动脉介入治疗
围手术期
临床研究
心肌保护
Unstable angina pectoris
Prethrombotic state
Danhong Injection
Metabolomics
Metabolic pathway
Perioperative PCI
Perioperative period
Clinical research
Myocardial protection